slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 65,701-65,730
Pages 3,679
Rows per page 30
Component
65,701-65,730 of 110,355
35
The slide uses a background diagram of biological pathways to illustrate complexity, overlaid with a callout box containing the core thesis.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
44
The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
45
The slide title mentions week 12, but the charts explicitly label week 24. This is a common discrepancy in clinical trial decks where data is presented across multiple time points.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
46
N=931. Data presented for Placebo, OCA 10mg, and OCA 25mg cohorts.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
47
The slide presents longitudinal data from the REGENERATE trial, specifically focusing on FIB-4 scores as a non-invasive test (NIT) for fibrosis.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
49
Figure 5 from a clinical study publication; includes legend for treatment arms.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
50
The slide uses a forest plot to visualize odds ratios and confidence intervals for clinical predictors.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
51
The slide uses a dark sidebar for context and a white main area for data presentation. It includes a citation at the bottom.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
52
The slide highlights the efficacy of MGL-3196 in NASH treatment using MRI-PDFF as a biomarker.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
53
Figure 3 from Stine JG, Munaganuru. Clin Gastroenterol Hepatol. 2021 Nov.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
55
The table compares Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID groups.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
58
The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
59
Includes a biological pathway diagram and patient population statistics.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
04
Includes stock market data and company operational status.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Humble Origins1 hit
06
The slide uses a comparative structure to highlight two distinct business models within their gaming portfolio.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
11
Uses a value chain comparison to illustrate efficiency gains.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
13
The slide uses a three-column layout to categorize the company's service offerings.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
15
The slide uses a value-chain style process flow to show the partnership mechanics.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
12
The slide uses two charts to demonstrate market validation: one for investment growth and one for pipeline expansion.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
13
The slide uses a before-after comparison structure to demonstrate the value of AI in pharma R&D.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
14
The slide uses a 2x2 matrix to map specific companies like BenevolentAI, Recursion, Exscientia, Schrodinger, and Relay Therapeutics.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
17
The slide uses a comparison framework to highlight competitive advantages in drug discovery efficiency.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
18
The chart uses a horizontal bar format to compare IND filing rates against market capitalization for different tiers of pharma companies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
22
The slide uses a three-column layout to categorize validation types: Internal Pipeline, Strategic, and Clinical/Regulatory.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
25
The slide uses a list-based structure to demonstrate the value proposition and validation of the company's AI platform.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
42
Includes a clinical photograph of the condition.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
43
Includes a biological mechanism diagram showing NGF, BDNF, and NTF-3 binding to TrkA, TrkB, and TrkC receptors.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
44
The slide uses a complex biological illustration to map specific receptor pathways to cellular mechanisms in AD skin.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
52
Includes a process diagram for biopsy analysis and a market segmentation breakdown.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit